whisper, page-36

Sportshow,

"i'm not sure that anyone would be in any great hurry to do deals with AVX, because as time goes on, the cost of purchasing the company only becomes cheaper."

Whilst that statement is true, we must remember that there are three companies who control most of the HIV treatments. In my opinion it is just a matter of time until one shows their hand, then a bidding war could begin. They will want to move pre PGL deal too.

Whilst avx hasn't been run well from an investment point of view, they still hold the most promising HIV treatment in the world. And still there has been no sign of resistance to the drug.

buy & hold, but there is risk - however much of that is priced in already.